We recently published a list of the 10 Best Performing Pharma Stocks So Far in 2025. In this article, we are going to take a look at where Verona Pharma plc (NASDAQ:VRNA) stands against the other best ...
Quarterly results from Block, Affirm and PayPal show that the major U.S. fintechs are converging as they all try to become ...
Shares of Match Group Inc. MTCH slid 3.25% to $32.77 Friday, on what proved to be an all-around rough trading session for the ...
Mizuho analyst Maheep Mandloi raised the firm’s price target on SolarEdge (SEDG) to $15 from $12 and keeps a Neutral rating on the shares. The ...
The debt-to-equity (D/E) ratio is a financial metric that helps determine the level of financial risk associated with a ...
The GeForce RTX 5070 Ti marries a solid leap in performance with Nvidia’s game-changing DLSS 4 Multi Frame Generation feature ...
KB Financial Group maintains a low nonperforming loan to total loans ratio, indicating quality loans. Check out my ...
Nvidia’s data-center sales could disappoint in the first half of the year but that's not a reason to sell the stock, ...
First Solar upgrade at Mizuho, citing a materially improved sales outlook after 2026 and a stronger competitive position in the U.S. market.
Shares of Axsome Therapeutics ( AXSM -0.49%) are up on Tuesday. The company's stock gained 4.1% as of 10:20 a.m. ET, but was ...
Dividend stocks can be terrific investments. The best ones provide investors with passive income and upside potential. Over ...
Mizuho upgraded First Solar (FSLR) to Outperform from Neutral with a price target of $259, up from $218. The company’s sales outlook post 2026 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results